Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titte R Srinivas

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 3, 2011
Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney diseaseSankar D Navaneethan, Jesse D Schold, Susana Arrigain, et al.
Nephrology (Carlton, Vic.)|September 11, 2018
Development and future deployment of a 5 years allograft survival model for kidney transplantationDerek A DuBay, Zemin Su, Thomas A Morinelli, et al.
Population Health Management|September 16, 2021
Redesigning Kidney Disease Care to Improve Value DeliveryTitte R Srinivas, Justin J Coran, Esther J Thatcher, et al.
Diabetes|November 15, 2018
The Familiality of Rapid Renal Decline in DiabetesScott G Frodsham, Zhe Yu, Ann M Lyons, et al.
Transplantation|June 29, 2017
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney TransplantationDavid J Taber, Zemin Su, James N Fleming, et al.
Social Science & Medicine (1982)|May 2, 2021
Type 1 Diabetes incidence among youth in Utah: A geographical analysisMatthew L McCullough, Neng Wan, Marcus G Pezzolesi, et al.
Transplantation Reviews (Orlando, Fla.)|August 5, 2019
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patientsJulio Pascual, Stefan P Berger, Steven J Chadban, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2025
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trialDixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 3, 2011
Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney diseaseSankar D Navaneethan, Jesse D Schold, Susana Arrigain, et al.
Nephrology (Carlton, Vic.)|September 11, 2018
Development and future deployment of a 5 years allograft survival model for kidney transplantationDerek A DuBay, Zemin Su, Thomas A Morinelli, et al.
Population Health Management|September 16, 2021
Redesigning Kidney Disease Care to Improve Value DeliveryTitte R Srinivas, Justin J Coran, Esther J Thatcher, et al.
Diabetes|November 15, 2018
The Familiality of Rapid Renal Decline in DiabetesScott G Frodsham, Zhe Yu, Ann M Lyons, et al.
Transplantation|June 29, 2017
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney TransplantationDavid J Taber, Zemin Su, James N Fleming, et al.
Social Science & Medicine (1982)|May 2, 2021
Type 1 Diabetes incidence among youth in Utah: A geographical analysisMatthew L McCullough, Neng Wan, Marcus G Pezzolesi, et al.
Transplantation Reviews (Orlando, Fla.)|August 5, 2019
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patientsJulio Pascual, Stefan P Berger, Steven J Chadban, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2019
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM studyStefan P Berger, Claudia Sommerer, Oliver Witzke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2025
Induction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trialDixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, et al.
Pageof 7